All News


 

2021

April

Media Release / Apr 09, 2021

Finalist at Les Mercuriades

Read More

February

Media Release / Feb 16, 2021

Sandoz Canada completes its 5th biosimilar launch with new biosimilar Hyrimoz® (adalimumab)

Read More

January

Media Release / Jan 26, 2021

Sandoz Canada launches the first generic versions of two original drugs: PrSandoz® Posaconazole and PrSandoz® Silodosin

Read More
Media Release / Jan 26, 2021

Novartis 2020 Financial Results

Read More
2020

December

Media Release / Dec 17, 2020

Sandoz Canada receives authorization from Health Canada to launch new biosimilar Hyrimoz® (adalimumab)

Read More

August

Media Release / Aug 19, 2020

Sandoz Canada launches two new biosimilars Ziextenzo® and Riximyo®

Read More

July

Media Release / Jul 16, 2020

Novartis in Canada certified as a Great Place to Work® for a second consecutive year

Read More

June

Media Release / Jun 25, 2020

Sandoz Canada Launches The Biosimilars Generation

Read More
Media Release / Jun 24, 2020

Novartis In Canada once again named to the list of Best Workplaces TM in Quebec

Read More
Media Release / Jun 11, 2020

Sandoz Canada Launches Injectable PrAmoxicillin Sodium and Potassium Clavulanate for Hospital Use

Read More